HIMS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HIMS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Hims & Hers Health's Total Assets for the quarter that ended in Dec. 2024 was $708 Mil.
Warning Sign:
If a company builds assets at 105.8% a year, faster than its revenue growth rate of 16.7% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Hims & Hers Health's average Total Assets Growth Rate was 85.00% per year. During the past 3 years, the average Total Assets Growth Rate was 33.00% per year. During the past 5 years, the average Total Assets Growth Rate was 105.80% per year.
During the past 6 years, Hims & Hers Health's highest 3-Year average Total Assets Growth Rate was 151.80%. The lowest was 33.00%. And the median was 128.40%.
Total Assets is connected with ROA %. Hims & Hers Health's annualized ROA % for the quarter that ended in Dec. 2024 was 15.90%. Total Assets is also linked to Revenue through Asset Turnover. Hims & Hers Health's Asset Turnover for the quarter that ended in Dec. 2024 was 0.73.
The historical data trend for Hims & Hers Health's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Total Assets | Get a 7-Day Free Trial | 118.70 | 420.59 | 366.34 | 441.19 | 707.54 |
Hims & Hers Health Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Total Assets | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
441.19 | 448.11 | 480.50 | 602.26 | 707.54 |
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Hims & Hers Health's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as
Total Assets | = | Total Equity (A: Dec. 2024 ) | + | Total Liabilities (A: Dec. 2024 ) |
= | 476.716 | + | 230.823 | |
= | 708 |
Hims & Hers Health's Total Assets for the quarter that ended in Dec. 2024 is calculated as
Total Assets | = | Total Equity (Q: Dec. 2024 ) | + | Total Liabilities (Q: Dec. 2024 ) |
= | 476.716 | + | 230.823 | |
= | 708 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health (NYSE:HIMS) Total Assets Explanation
Total Assets is connected with ROA %.
Hims & Hers Health's annualized ROA % for the quarter that ended in Dec. 2024 is
ROA % | = | Net Income (Q: Dec. 2024 ) | / | ( (Total Assets (Q: Sep. 2024 ) | + | Total Assets (Q: Dec. 2024 )) | / count ) |
= | 104.1 | / | ( (602.261 | + | 707.539) | / 2 ) | |
= | 104.1 | / | 654.9 | ||||
= | 15.90 % |
Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Hims & Hers Health's Asset Turnover for the quarter that ended in Dec. 2024 is
Asset Turnover | ||||||
= | Revenue (Q: Dec. 2024 ) | / | ( (Total Assets (Q: Sep. 2024 ) | + | Total Assets (Q: Dec. 2024 )) | / count ) |
= | 481.139 | / | ( (602.261 | + | 707.539) | / 2 ) |
= | 481.139 | / | 654.9 | |||
= | 0.73 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Thank you for viewing the detailed overview of Hims & Hers Health's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Irene Becklund | officer: Interim PFO/PAO | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Patrick Harrison Carroll | officer: Chief Medicall Officer | 2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123 |
Soleil Boughton | officer: See Remarks | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Andrew Dudum | director, 10 percent owner, officer: Chief Executive Officer | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Christiane Pendarvis | director | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Michael Chi | officer: Chief Marketing Officer | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Melissa Baird | officer: Chief Operating Officer | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Oluyemi Okupe | officer: Chief Financial Officer | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
David B Wells | director | C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130 |
Lynne Chou O'keefe | director | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Alex Bard | director | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Jules A. Maltz | director | 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025 |
Ivp Executive Fund Xvi, Llc | 10 percent owner | 3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025 |
Somesh Dash | 10 percent owner | 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025 |
Jack Abraham | 10 percent owner | 1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129 |
From GuruFocus
By GuruFocus News • 03-06-2025
By GuruFocus News • 03-18-2025
By GuruFocus News • 03-03-2025
By Khac Phu Nguyen • 03-06-2025
By GuruFocus News • 03-18-2025
By GuruFocus News • 02-28-2025
By GuruFocus News • 03-13-2025
By Khac Phu Nguyen • 02-21-2025
By Khac Phu Nguyen • 02-25-2025
By GuruFocus News • 02-26-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.